JPH0214326B2 - - Google Patents
Info
- Publication number
- JPH0214326B2 JPH0214326B2 JP56056933A JP5693381A JPH0214326B2 JP H0214326 B2 JPH0214326 B2 JP H0214326B2 JP 56056933 A JP56056933 A JP 56056933A JP 5693381 A JP5693381 A JP 5693381A JP H0214326 B2 JPH0214326 B2 JP H0214326B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- feed
- parts
- macrotetrolide
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 19
- 230000003115 biocidal effect Effects 0.000 claims description 16
- 239000002736 nonionic surfactant Substances 0.000 claims description 16
- 244000144972 livestock Species 0.000 claims description 9
- 244000144977 poultry Species 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000003904 antiprotozoal agent Substances 0.000 claims description 2
- 239000007952 growth promoter Substances 0.000 claims description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 27
- -1 glycerin fatty acid ester Chemical class 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000004534 cecum Anatomy 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- CTZNINKRTKCWGU-UHFFFAOYSA-N Dinactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 CTZNINKRTKCWGU-UHFFFAOYSA-N 0.000 description 5
- NKNPHSJWQZXWIX-DCVDGXQQSA-N Tetranactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](CC)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](CC)OC(=O)[C@H]1C)CC)C(=O)O[C@H](CC)C[C@H]2CC[C@@H]1O2 NKNPHSJWQZXWIX-DCVDGXQQSA-N 0.000 description 5
- NKNPHSJWQZXWIX-UHFFFAOYSA-N Tetranactin Natural products CC1C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC2CCC1O2 NKNPHSJWQZXWIX-UHFFFAOYSA-N 0.000 description 5
- ZBDGIMZKOJALMU-MVWQHRGOSA-N dinactin Chemical compound C[C@@H]([C@@H]1CC[C@@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@H]1CC[C@H](O1)C[C@@H](C)OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@H](CC)OC(=O)[C@H]1C)CC)C(=O)O[C@H](C)C[C@@H]2CC[C@H]1O2 ZBDGIMZKOJALMU-MVWQHRGOSA-N 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- DFQMKYUSAALDDY-MQEBUAKTSA-N trinactin Chemical compound C[C@@H]([C@@H]1CC[C@@H](O1)C[C@H](OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](CC)OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](CC)OC(=O)[C@@H]1C)CC)C(=O)O[C@@H](C)C[C@@H]2CC[C@H]1O2 DFQMKYUSAALDDY-MQEBUAKTSA-N 0.000 description 5
- DFQMKYUSAALDDY-UHFFFAOYSA-N trinactin Natural products CC1C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 DFQMKYUSAALDDY-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 206010028140 Mucous stools Diseases 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 208000027503 bloody stool Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RMIXHJPMNBXMBU-UHFFFAOYSA-N Nonactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 RMIXHJPMNBXMBU-UHFFFAOYSA-N 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RMIXHJPMNBXMBU-QIIXEHPYSA-N Nonactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](C)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](C)OC(=O)[C@H]1C)C)C(=O)O[C@H](C)C[C@H]2CC[C@@H]1O2 RMIXHJPMNBXMBU-QIIXEHPYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 241000589886 Treponema Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000001165 anti-coccidial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000003250 oocyst Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- YPUPRVWRYDPGCW-UHFFFAOYSA-N Monactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 YPUPRVWRYDPGCW-UHFFFAOYSA-N 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- YPUPRVWRYDPGCW-GGOMOPATSA-N monactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](C)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](C)OC(=O)[C@H]1C)CC)C(=O)O[C@H](C)C[C@H]2CC[C@@H]1O2 YPUPRVWRYDPGCW-GGOMOPATSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明はマクロテトロライド系抗生物質及び非
イオン界面活性剤を含有する家畜・家禽用抗菌・
抗原虫剤及び生長促進剤に関する。
近年、マクロテトロライド系抗生物質に家畜・
家禽の成長促進、飼料効率の向上、疾病の予防及
び治療などの効果のあるとが見出され、その実用
化が期待されている。
しかし、マクロテトロライド系抗生物質のin―
vitvoにおける効果とin―vivoにおける効果が必
ずしも一致せず、in―vivoにおける効果の発明が
充分でなく、そのため、投与量を増やさなければ
ならないという問題がある。
そこで、本発明者らはマクロテトロライド系抗
生物質の効果がin―vivoにおいても充分発揮しう
るようにするため、種々検討をおこなつた結果、
マクロテトロライド系抗生物質及び非イオン界面
活性剤を含有する組成物を家畜・家禽に経口的に
投与することにより、その効果が充分発揮され、
投与量を減らしても発育促進効果などが充分発現
されることを見出した。
本発明は上記知見により完成されたものであ
る。
本発明で使用されるマクロテトロライド系抗生
物質としては例えばノナクチン、モナクチン、ジ
ナクチン、トリナクチン、テトラナクチンなどが
あげられる。これらは混合して使用してもよい。
非イオン界面活性剤としては例えばグリセリン
脂肪酸エステル、シヨ糖脂肪酸エステル、プロピ
レングリコール脂肪酸エステル、ポリオキシエチ
レン脂肪酸エステル、ポリオキシエチレングリセ
リン脂肪酸エステル、ポリオキシエチレンソルビ
タン脂肪酸エステル、ポリオキシエチレン硬化ヒ
マシ油誘導体などがあげられるが、ポリオキシエ
チレン脂肪酸エステル、ポリオキシエチレングリ
セリン脂肪酸エステル、ポリオキシエチレンソル
ビタン脂肪酸エステル、ポリオキシエチレン硬化
ヒマシ油誘導体などのポリオキシエチレン系の非
イオン界面活性剤が好ましい。これらは混合して
使用してもよい。
マクロテトロライド系抗生物質と非イオン界面
活性剤との使用比率は前者1重量部に対し、後者
1重量部以上、好ましくは1―1000重量部、さら
に好ましくは1〜100重量部がよい。
本発明の製剤はマクロテトロライド系抗生物質
及び非イオン界面活性剤とを含有しているもので
あれば特に制限はないが、例えば上記2者を混合
しただけのもの、上記2者と賦形剤とを混合した
製剤又は上記2者を含有する飼料などがあげられ
る。
賦形剤としては例えば小麦粗粉、小麦スソ粉、
大豆粗粉、大豆油かす、コーンスターチ、コーン
ミール、脱脂米糠、ふすま、甘薯でんぷん、乳
糖、酵母、油脂、炭酸カルシウム、タルク、木質
粉末、カリオン、白亜珪藻土、水、生理的食塩水
等があげられる。
飼料としては市販されている家畜・家禽用飼料
であればよく、例えばトウモロコシ、マイロなど
の穀類、大豆粕などの食用油粕、フスマ、米糠な
どの糟糠類、コーングルテンミール、でんぷん
粕、しよう油粕、糖蜜などの製造粕類、肉骨粉、
魚粉、ホエー、脱脂粉乳、血粉、フエザーミー
ル、動物性油脂などの動物質類、などの飼料原料
を適当な割合に混合したもの、又はさらにミネラ
ル、ビタミン、アミノ酸などの飼料添加物を加え
て作つた飼料でもよい。
本発明の製剤を製造するにはマクロテトロライ
ド系抗生物質を揮発しやすい有機溶媒、例えばメ
タノール、エタノール、アセトン、クロロホル
ム、ベンゼンなどに溶解し、これに非イオン界面
活性剤を混合後、有機溶媒を除去すればよい。
非イオン界面活性剤が固体の場合には、それを
加熱熔融後上記有機溶媒に溶かしたマクロテトロ
ライド系抗生物質と混合し、その後溶媒を除去
し、粉末とすればよい。又、賦形剤を使用する場
合は、マクロテトロライド系抗生物質及び、非イ
オン界面活性剤を賦形剤に別々に混合してもよい
が、上記混合物に賦形剤を添加して均一に混合す
る方が非イオン界面活性剤の使用量が少なくてす
み好ましい。
本発明の製剤中のマクロテトロライド系抗生物
質の濃度はその組成により異なるので一概にはい
えないが、製剤全体に対して0.0001%(以下特に
断わらない限り%は重量%を示す。)以上、好ま
しくは0.0005〜50%であり、例えばマクロテトロ
ライド系抗生物質、非イオン系界面活性剤及び賦
形剤からなる製剤の場合には0.1〜40%が好まし
く、マクロテトロライド系抗生物質及び非イオン
界面活性剤を含む飼料組成物の場合には0.0001%
〜0.1%、好ましくは0.0005〜0.05%である。
本発明の製剤を含む好ましい組成物を示すとマ
クロテトロライド系抗生物質0.0005〜40%、非イ
オン界面活性剤0.0005〜95%、経済的には0.001
〜60%及び残部は賦形剤及び/又は飼料からな
り、かつマクロテトロライド系抗生物質1重量部
に対し、非イオン界面活性剤が1〜1000重量部好
ましくは1〜200重量部の範囲にある組成物であ
る。この組成物は必要に応じて、更に一般に使用
される製剤用の助剤や飼料添加物を含んでもよ
い。
以上のようにして製造された本発明の製剤を家
畜及び家禽に経口的に連続的に投与することによ
り、マクロテトロライド系抗生物質が、それ単独
で投与する場合より有効に作用し、成長促進、飼
料効率の向上、疾病の予防及び治療などの効果が
充分発揮される。
本発明の製剤を投与する家畜・家禽は特に制限
はないが、実用的観点からすると牛、豚、鶏など
が好ましい。
又、その投与量は有効成分であるマクロテトロ
ライド系抗生物質として0.025mg/Kg/日以上、
好ましくは0.125〜12.5mg/Kg/日がよい。又、
その投与形態としては製剤をそのまま、又、マク
ロテトロライド系抗生物質と非イオン界面活性剤
からなる製剤又はそれと賦形剤とからなる製剤の
場合には散剤、錠剤、顆粒としてこれらを飼料や
飲水に混合して投与してもよい。
次に本発明の製剤がすぐれた効果をもつもので
あることを実施例により示す。
実験例 1
豚赤痢の感染防禦試験
(1) 試料の調製
ポリナクチン(成分割合はジナクチン:トリ
ナクチン:テトラナクチン=1:2:7)1重
量部をアセトン20重量部に溶解し、次いでその
溶液に非イオン界面活性剤10重量部を添加して
均一に混合溶解し、次いでこの溶液に脱脂米糠
89重量部を添加、均一に混合した後アセトンを
揮散させて粉末状の混合物としたものを表1に
示す基礎飼料にポリナクチン濃度0.003%にな
るように添加して得られた本発明組成物(C〜
I)の7点を試料とした。又、飼料単独(A)、ポ
リナクチンのみを0.003%添加した飼料(B)を対
照飼料とした。
The present invention is an antibacterial product for livestock and poultry containing a macrotetrolide antibiotic and a nonionic surfactant.
This invention relates to antiprotozoal agents and growth promoters. In recent years, macrotetrolide antibiotics have been used in livestock and
It has been found to be effective in promoting the growth of poultry, improving feed efficiency, and preventing and treating diseases, and its practical application is expected. However, the in-
There is a problem that the effect in vivo and the effect in in-vivo do not necessarily match, and the in-vivo effect has not been sufficiently discovered, and therefore the dosage must be increased. Therefore, the present inventors conducted various studies in order to ensure that the effects of macrotetrolide antibiotics can be fully demonstrated in-vivo.
By orally administering a composition containing a macrotetrolide antibiotic and a nonionic surfactant to livestock and poultry, its effects are fully exhibited,
It has been found that even if the dose is reduced, the growth promoting effect etc. can be sufficiently expressed. The present invention was completed based on the above findings. Examples of macrotetrolide antibiotics used in the present invention include nonactin, monactin, dinactin, trinactin, and tetranactin. These may be used in combination. Examples of nonionic surfactants include glycerin fatty acid ester, sucrose fatty acid ester, propylene glycol fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil derivative, etc. However, polyoxyethylene-based nonionic surfactants such as polyoxyethylene fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene hydrogenated castor oil derivatives are preferred. These may be used in combination. The ratio of the macrotetrolide antibiotic to the nonionic surfactant is 1 part by weight of the former to 1 part by weight or more of the latter, preferably 1 to 1000 parts by weight, and more preferably 1 to 100 parts by weight. The preparation of the present invention is not particularly limited as long as it contains a macrotetrolide antibiotic and a nonionic surfactant; Examples include preparations in which the above-mentioned agents are mixed together, and feeds containing the above-mentioned two agents. Examples of excipients include coarse wheat flour, wheat soot flour,
Examples include coarse soybean powder, soybean oil cake, cornstarch, cornmeal, defatted rice bran, wheat bran, sweet potato starch, lactose, yeast, fats and oils, calcium carbonate, talc, wood powder, carillon, chalk diatomaceous earth, water, physiological saline, etc. . The feed may be any commercially available feed for livestock and poultry, such as grains such as corn and milo, edible oil meal such as soybean meal, bran such as bran and rice bran, corn gluten meal, starch meal, soybean oil meal, etc. Manufactured lees such as molasses, meat and bone meal,
It is made by mixing feed ingredients such as fish meal, whey, skim milk powder, blood meal, feather meal, animal substances such as animal fats and oils in appropriate proportions, or by adding feed additives such as minerals, vitamins, and amino acids. It can also be feed. To produce the formulation of the present invention, a macrotetrolide antibiotic is dissolved in a volatile organic solvent such as methanol, ethanol, acetone, chloroform, benzene, etc., and a nonionic surfactant is mixed therein. Just remove it. When the nonionic surfactant is solid, it may be heated and melted, then mixed with the macrotetrolide antibiotic dissolved in the above-mentioned organic solvent, and then the solvent may be removed to form a powder. In addition, when using an excipient, the macrotetrolide antibiotic and the nonionic surfactant may be mixed separately with the excipient, but the excipient may be added to the above mixture to ensure uniformity. Mixing is preferable because the amount of nonionic surfactant used can be reduced. The concentration of the macrotetrolide antibiotic in the preparation of the present invention varies depending on its composition, so it cannot be stated unconditionally, but it is 0.0001% (hereinafter, % indicates weight % unless otherwise specified) or more based on the entire preparation, It is preferably 0.0005 to 50%, for example, in the case of a formulation consisting of a macrotetrolide antibiotic, a nonionic surfactant, and an excipient, 0.1 to 40% is preferable; 0.0001% for feed compositions containing surfactants
~0.1%, preferably 0.0005-0.05%. A preferred composition containing the preparation of the present invention includes 0.0005 to 40% macrotetrolide antibiotic, 0.0005 to 95% nonionic surfactant, and 0.001% economically.
~60% and the remainder consists of excipients and/or feed, and the nonionic surfactant is in the range of 1 to 1000 parts by weight, preferably 1 to 200 parts by weight, per 1 part by weight of the macrotetrolide antibiotic. It is a certain composition. This composition may further contain commonly used formulation auxiliaries and feed additives, if necessary. By continuously orally administering the preparation of the present invention produced as described above to livestock and poultry, the macrotetrolide antibiotic acts more effectively than when administered alone, promoting growth. , the effects of improving feed efficiency, preventing and treating diseases, etc. are fully demonstrated. There are no particular restrictions on the livestock/poultry to which the preparation of the present invention is administered, but from a practical standpoint, cows, pigs, chickens, etc. are preferred. In addition, the dosage is 0.025 mg/Kg/day or more as the active ingredient macrotetrolide antibiotic,
Preferably 0.125 to 12.5 mg/Kg/day. or,
The dosage form is the preparation as it is, or in the case of a preparation consisting of a macrotetrolide antibiotic and a nonionic surfactant, or a preparation consisting of it and an excipient, it can be administered as a powder, tablet, or granule in feed or drinking water. It may also be administered by mixing with Next, examples show that the formulation of the present invention has excellent effects. Experimental example 1 Infection prevention test for swine dysentery (1) Sample preparation Dissolve 1 part by weight of polynactin (component ratio: dinactin: trinactin: tetranactin = 1:2:7) in 20 parts by weight of acetone, and then add nonionic to the solution. Add 10 parts by weight of surfactant, mix and dissolve uniformly, then add defatted rice bran to this solution.
The composition of the present invention obtained by adding 89 parts by weight, uniformly mixing, and volatilizing the acetone to form a powder mixture was added to the basal feed shown in Table 1 so that the polynactin concentration was 0.003% ( C~
Seven points of I) were used as samples. In addition, feed alone (A) and feed containing only 0.003% polynactin (B) were used as control feeds.
【表】【table】
【表】
(2) 試験方法
体重約12Kgの子豚(LWD種)を1群当り5
頭(去勢雄)用い、各試料を自由摂取させ、試
料の摂取開始後3日目に、トレポネーマ・ハイ
オデイセンテリアの純粋培養寒天を1頭当り10
枚経口投与し人工感染させた。人工感染後21日
間糞便の状態を観察した。
(3) 試験結果
結果を表2に示す。[Table] (2) Test method Five piglets (LWD breed) weighing approximately 12 kg were tested per group.
Using a castrated male head, each animal was allowed to take in each sample ad libitum, and on the 3rd day after the start of ingestion of the sample, 10 pieces of pure culture agar of Treponema hyodeisenteriae were added to each animal.
Artificial infection was caused by oral administration. The state of feces was observed for 21 days after artificial infection. (3) Test results The results are shown in Table 2.
【表】【table】
【表】
注2) 粘血便からはすべてトレポネーマハイ
オデイセンテリアが検出され、粘血便は豚赤
痢によるものであることを確認した。
表2から明らかなように本発明の試料C〜Iは
対照試料A,Bに比し、粘血便の発生例が少なく
又発生時期も遅くなり、さらに試験終了時には全
例消失した。特にポリオキシエチレン系界面活性
剤を使用した試料C〜Fでは粘血便の発生例がな
く、豚赤痢の予防効果が十分達成されていること
がわかる。
実験例 2
鶏によるコクシジウムの感染防禦試験
(1) 試料の調製
ポリナクチン(成分割合はジナクチン:トリ
ナクチン:テトラナクチン=1:4:5)1重
量部をアセトン20重量部に溶解し、次いでその
溶液に非イオン界面活性剤20重量部を添加して
均一に混合溶解し、次いでこの溶液にコーンス
ターチ79重量部を添加、均一に混合した後アセ
トンを揮散させて粉末状の混合物としたものを
表3に示す基礎飼料にポリナクチン濃度が
0.002%になるように添加した本発明組成物C
〜Hの6点を試料とした。又、飼料単独(A)、ポ
リナクチンのみを0.002%添加した飼料(B)を対
照試料とした。[Table] Note 2) Treponema hyodeisenteriae was detected in all mucus and bloody stools, confirming that the mucus and bloody stools were caused by swine dysentery. As is clear from Table 2, samples C to I of the present invention had fewer instances of mucus and bloody stool than control samples A and B, and the occurrence time was delayed, and furthermore, all cases had disappeared by the end of the test. In particular, samples C to F in which polyoxyethylene surfactants were used did not have mucus and bloody stools, indicating that the preventive effect on swine dysentery was sufficiently achieved. Experimental Example 2 Coccidia Infection Prevention Test by Chickens (1) Sample Preparation 1 part by weight of polynactin (component ratio: dinactin: trinactin: tetranactin = 1:4:5) was dissolved in 20 parts by weight of acetone, and then the solution was 20 parts by weight of ionic surfactant was added and mixed and dissolved uniformly, then 79 parts by weight of cornstarch was added to this solution, and after uniformly mixing, acetone was volatilized to form a powder mixture, which is shown in Table 3. Polynactin concentration in basal feed
Composition C of the present invention added to 0.002%
Six points from ~H were used as samples. In addition, feed alone (A) and feed containing only 0.002% polynactin (B) were used as control samples.
【表】
(2) 試験方法
ブロイラー(アーバーエーカ種)の雌ビナを
1群当り5羽用いた。ヒナを初日令から5日間
薬物を含まない基礎飼料で飼育した後、6日令
より各試料を与え始めた。そして8日令にアイ
メリカテネラのオーシストを1羽当り、2×
104個経口投与し、人工感染させた。オーシス
ト投与後8日目にヒナを剖検し、盲腸の病変程
度を観察し、コクシジウム感染の程度を判断し
た。
盲腸病変は次の5段階に分けて判定規準とし
た。
−……盲腸は全く正常
+……盲腸の形は正常。内容物はやゝ流動性を
帯び色も黄色がかる。盲腸粘膜は部分的に
軽度の腫脹があり白つぽくなる。
……盲腸の形はほゞ正常、粘膜の腫脹は全面
にみられる。内容に出血はなく、粘液は黄
色をおび褪色している。粘膜内には少数の
白色点状壊死巣や、出血斑がみられる。
……盲腸の萎縮変形は明瞭で直腸よりもやや
長い程度となる。正常な内容物は全くなく
凝血又は灰白色チーズ状の変性物が充満し
ていることが多い。
盲腸壁の肥厚は顕著でもろくなり、点状出
血斑がまだ残つていることもある。病変は
盲腸基部にまで達するが直腸にまで達しな
い。
〓……盲腸の萎縮、変形は顕著、一般にソーセ
ージ状を呈し、その長さは直腸と同じか、
又は短かくなつている。
病変は直腸の1/3〜1/4位の所にまで達す
る。その他はと同じである。
(3) 試験結果
試験結果を表4に示す。[Table] (2) Test method Five female broiler chickens (Arbor Acre species) were used per group. After the chicks were raised on a drug-free basal diet for 5 days from the first day of age, feeding of each sample was started from the 6th day of age. Then, at 8 days old, oocysts of Eimericatenella were added to each bird, 2×
104 were orally administered to cause artificial infection. On the 8th day after administration of the oocysts, the chicks were necropsied, the degree of lesions in the cecum was observed, and the degree of coccidia infection was determined. Cecal lesions were classified into the following five grades as criteria for evaluation. −……The cecum is completely normal. +……The shape of the cecum is normal. The contents are slightly fluid and yellowish in color. The cecal mucosa is slightly swollen and whitish. ...The shape of the cecum is almost normal, and swelling of the mucous membrane is visible all over. There is no bleeding in the contents, and the mucus is yellow and discolored. A small number of white punctate necrotic foci and hemorrhagic spots are seen within the mucosa. ...The atrophic deformity of the cecum is clear and it is slightly longer than the rectum. It is often devoid of any normal contents and filled with blood clots or off-white cheese-like degeneration. The cecal wall becomes noticeably thickened and brittle, and petechiae may still remain. The lesions extend to the base of the cecum but not to the rectum. 〓...The atrophy and deformation of the cecum are noticeable, generally sausage-shaped, and its length may be the same as that of the rectum.
Or it's getting shorter. The lesion extends to 1/3 to 1/4 of the rectum. Others are the same. (3) Test results The test results are shown in Table 4.
【表】
表4から明らかなように本発明の試料C〜Hは
対照飼料A,Bよりも抗コクシジウム効果がすぐ
れ、特にポリオキシエチレン系界面活性剤を使用
した試料C〜Eの抗コハクシジウム効果がすぐれ
ていた。
実験例 3
反芻家畜による発育促進試験
(1) 飼料の調製
ポリナクチン(成分割合はジナクチン:トリ
ナクチン:テトラナクチン=1:4:5)1重
量部をアセトン20重量部に溶解し、次いでその
溶液に非イオン界面活性剤20重量部を添加して
均一に混合溶解し、次いでこの溶液にフスマ69
重量部を添加、均一に混合した後アセトンを揮
散させて粉末状の混合物としたものを表5に示
す基礎飼料にポリナクチン濃度が0.005%にな
るように添加した本発明組成物C〜Fの4点を
試料とした。又、飼料単独(A)、ポリナクチンの
みを0.005%添加した飼料(B)を対照試料とした。[Table] As is clear from Table 4, Samples C to H of the present invention have better anti-coccidial effects than Control Feeds A and B, and especially Samples C to E using polyoxyethylene surfactants have anti-coccidial effects. The effect was excellent. Experimental Example 3 Growth promotion test using ruminant livestock (1) Preparation of feed 1 part by weight of polynactin (component ratio: dinactin: trinactin: tetranactin = 1:4:5) was dissolved in 20 parts by weight of acetone, and then non-ionized was added to the solution. Add 20 parts by weight of surfactant and mix and dissolve uniformly, then add wheat bran 69 to this solution.
Parts by weight were added, uniformly mixed, and then the acetone was volatilized to form a powder mixture, which was added to the basal feed shown in Table 5 so that the polynactin concentration was 0.005%. A point was used as a sample. In addition, feed alone (A) and feed containing only 0.005% polynactin (B) were used as control samples.
【表】【table】
【表】
(2) 試験方法
体重約25Kgの緬羊(サフオーク種)を1群当
り4頭(♀2〓2)用い、試料を自由摂取さ
せ、試験開始時及び開始7週間後の体重を測定
し、又、その間の飼料摂取量も測定し、増体量
及び飼料要求率を求めた。
(3) 試験結果
結果を表6に示す。[Table] (2) Test method Four sheep (Suffoak breed) weighing approximately 25 kg were used per group (♀2〓2), and the sheep were given free access to samples, and their body weights were measured at the start of the test and 7 weeks after the start of the test. In addition, feed intake during that period was also measured, and body weight gain and feed conversion ratio were determined. (3) Test results The results are shown in Table 6.
【表】【table】
【表】
表6から明らかなように本発明の試料C〜Fは
対照試料A,Bよりも増体量、飼料要求率ともに
すぐれ、発育促進増強効果及び飼料効率の改善が
認められた。
次に本発明の組成物の製造を実施例により説明
する。
実施例 1
ノナクチン1重量部をアセトン40重量部に溶解
し、次いでこの溶液にポリオキシエチレンソルビ
タンモノオレエート10重量部を添加して撹拌混合
し、均一の溶液状の組成物を得た。
実施例 2
実施例1で得られた液状組成物11重量部に脱脂
米糠89重量部に加えて混合し、次いでアセトンを
揮散させて粉末状の組成物を得た。
実施例 3
ポリナクチン(ジナクチン:トリナクチン:テ
トラナクチン=1:4:5)1重量部にアセトン
20重量部に溶解し、これを60℃に加熱熔融したポ
リオキシエチレン硬化とヒマシ油誘導体50重量部
に加えて撹拌混合し、均一の液状組成物とする。
次いでアセトンを揮散させた後冷却固化、次いで
粉砕して粉末状の組成物を得た。
実施例 4
実施例2で得た組成物5重量部を市販配合飼料
1000重量部に添加し、均一に混合して飼料組成物
を得た。[Table] As is clear from Table 6, Samples C to F of the present invention were superior to Control Samples A and B in both body weight gain and feed conversion rate, and were found to have a growth promoting effect and an improvement in feed efficiency. Next, the production of the composition of the present invention will be explained with reference to Examples. Example 1 1 part by weight of nonactin was dissolved in 40 parts by weight of acetone, and then 10 parts by weight of polyoxyethylene sorbitan monooleate was added to this solution and mixed with stirring to obtain a uniform solution composition. Example 2 89 parts by weight of defatted rice bran were added to 11 parts by weight of the liquid composition obtained in Example 1 and mixed, and then acetone was evaporated to obtain a powdered composition. Example 3 Add acetone to 1 part by weight of polynactin (dinactin: trinactin: tetranactin = 1:4:5)
This is added to 50 parts by weight of cured polyoxyethylene and castor oil derivative heated and melted at 60°C, and stirred and mixed to form a uniform liquid composition.
Next, after volatilizing the acetone, the mixture was cooled and solidified, and then pulverized to obtain a powdery composition. Example 4 5 parts by weight of the composition obtained in Example 2 was added to commercially available mixed feed.
It was added to 1000 parts by weight and mixed uniformly to obtain a feed composition.
Claims (1)
界面活性剤を含有する家畜・家禽用抗菌・抗原虫
剤。 2 マクロテトロライド系抗生物質及び非イオン
界面活性剤を含有する家畜・家禽用生長促進剤。[Claims] 1. An antibacterial/antiprotozoal agent for livestock and poultry containing a macrotetrolide antibiotic and a nonionic surfactant. 2. A growth promoter for livestock and poultry containing a macrotetrolide antibiotic and a nonionic surfactant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56056933A JPS57171919A (en) | 1981-04-17 | 1981-04-17 | Orally administering composition for veterinary purposes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56056933A JPS57171919A (en) | 1981-04-17 | 1981-04-17 | Orally administering composition for veterinary purposes |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57171919A JPS57171919A (en) | 1982-10-22 |
JPH0214326B2 true JPH0214326B2 (en) | 1990-04-06 |
Family
ID=13041312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56056933A Granted JPS57171919A (en) | 1981-04-17 | 1981-04-17 | Orally administering composition for veterinary purposes |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57171919A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260271A (en) * | 1988-06-22 | 1993-11-09 | Applied Microbiology, Inc. | Nisin compositions for use as enhanced broad range bactericides |
AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
JP6242655B2 (en) * | 2013-10-29 | 2017-12-06 | リンテック株式会社 | Release method of functional substance, kit for releasing functional substance, and release composition |
-
1981
- 1981-04-17 JP JP56056933A patent/JPS57171919A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57171919A (en) | 1982-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1913943B1 (en) | Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria | |
WO1991011111A1 (en) | Method of raising meat producing animals to increase lean tissue development | |
JP2002538845A (en) | Pet food for maintaining joint health and reducing the signs of arthritis in pet animals | |
JP2000515864A (en) | Conjugated linoleic acid for maintaining or increasing bone mineral content | |
US20100105867A1 (en) | Process for producing osteocalcin-containing extract | |
EP0941088B1 (en) | Use of conjugated linoleic acid to enhance natural killer lymphocyte function | |
EP0460080B1 (en) | Orally administerable calcium supplement for cattle | |
JP2005509602A (en) | Composition for versatile dairy animals | |
US20060034781A1 (en) | Peroral preparation for prevention or treatment of atopic dermatatis | |
JPH0214326B2 (en) | ||
EP0342111B1 (en) | Process for increasing the productivity of sows | |
JPH0556755A (en) | Livestock feed additive and livestock feed | |
US20230040395A1 (en) | Composition for suppressing obesity | |
US3916027A (en) | Method of treating candida albicans infections in poultry | |
US20130136724A1 (en) | Pig feed, and method for feeding same | |
HU182652B (en) | Process for producing food-additives containing antibiotics | |
EP0237956B1 (en) | Method of feeding ketoisocaproate to lactating domestic mammals | |
EP0424055B1 (en) | Feedstuffs | |
US3943250A (en) | Method and pharmaceutical preparations for treating and preventing physiological disturbances in vertebrates, caused by molds and yeasts | |
US3714361A (en) | Certain hydroxamic acids as growth promoting agents | |
JPH06701B2 (en) | Veterinary composition | |
EP0589105B1 (en) | Improvement in livestock raising | |
JP2007116972A (en) | Bone fracture preventive agent, and slipped tendon preventive agent | |
JP3212364B2 (en) | New royal jelly formulation | |
JP2007104954A (en) | Feed additive |